Table 1.
Scoring from the modified Downs and Black Checklist assessing risk of bias. Certain items were not applicable to all studies
Downs and Black Checklist item | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Authors | 1 Hypothesis described |
2 Main outcome described |
3 Patient characteristics described |
6 Main finding described |
7 Estimates of outcome variability |
9 Characteristics of patient lost to follow-up |
10 Actual probability values |
11 Subjects asked to participate representative |
12 Subjects prepared to participate representative |
16 Results based on data dredging made clear |
17 Different length of follow-up adjusted |
18 Appropriate statistics |
20 Outcome valid and reliable |
25 Adjustment for confounders |
26 Loss to follow-up taken into account |
27 Sufficient power |
Sum |
Askling et al. [19] | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 11 |
Askling et al. [31] | 1 | 1 | 1 | 1 | 1 | 1 | N/A | 0 | 0 | 1 | N/A | 1 | 1 | N/A | 1 | 0 | 10 |
Chumanov et al. [34] | 1 | 1 | 1 | 1 | 1 | N/A | 1 | N/A | N/A | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 9 |
Fiorentino et al. [32] | 1 | 1 | 1 | 1 | 1 | N/A | N/A | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | N/A | 8 |
Hanley et al. [35] | 1 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 9 |
Hanley et al. [36] | 1 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 9 |
Heiderscheit et al. [37] | 1 | 1 | 1 | 1 | 1 | N/A | N/A | N/A | N/A | 1 | N/A | 1 | 1 | N/A | N/A | N/A | 8 |
Higashihara et al. [38] | 1 | 1 | 1 | 1 | 1 | N/A | 0 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 8 |
Higashihara et al. [39] | 1 | 1 | 1 | 1 | 1 | N/A | 0 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 8 |
Jones et al. [40] | 1 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 9 |
Mann et al. [28] | 0 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | N/A | 8 |
Montgomery III et al. [33] | 1 | 1 | 1 | 1 | 1 | N/A | 0 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 8 |
Ono et al. [41] | 1 | 1 | 1 | 1 | 1 | N/A | N/A | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 8 |
Padulo et al. [42] | 1 | 1 | 1 | 1 | 1 | N/A | 0 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 8 |
Prior et al. [43] | 1 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 5 | 14 |
Ruan et al. [44] | 1 | 1 | 1 | 1 | 1 | N/A | 0 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 8 |
Sallay et al. [45] | 1 | 1 | 1 | 1 | 1 | N/A | N/A | 0 | 0 | 1 | 1 | N/A | 1 | N/A | N/A | N/A | 8 |
Schache et al. [46] | 1 | 1 | 1 | 1 | 1 | N/A | N/A | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | N/A | 8 |
Schache et al. [47] | 1 | 1 | 1 | 1 | 1 | N/A | N/A | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | N/A | 8 |
Schache et al. [48] | 1 | 1 | 1 | 1 | 1 | N/A | N/A | N/A | N/A | 1 | N/A | 1 | 1 | N/A | N/A | N/A | 8 |
Schuermans et al. [49] | 1 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 0 | 1 | N/A | 1 | 1 | 1 | N/A | 0 | 10 |
Schuermans et al. [50] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 11 |
Sun et al. [51] | 1 | 1 | 1 | 1 | 1 | N/A | N/A | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | N/A | 8 |
Thelen et al. [52] | 1 | 1 | 0 | 1 | 1 | N/A | 0 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 7 |
Wan et al. [53] | 1 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 9 |
Yu et al. [54] | 1 | 1 | 1 | 1 | 1 | N/A | 1 | 0 | 0 | 1 | N/A | 1 | 1 | N/A | N/A | 0 | 9 |
N/A Not applicable